iOrganBio raises $2M in funding led by First Star Ventures to launch CellForge™, a groundbreaking AI-powered cell manufacturing platform.

Oct 29, 2025•3 days ago

Amount Raised

$2 Million

Round Type

seed

Chapel HillBiotechnology

Investors

Alix VenturesTerasaki Institute2nd FCape Fear Bio CapitalIndie BioFirst Star Ventures

Description

iOrganBio has emerged from stealth with $2 million in funding to revolutionize human cell manufacturing. This funding round was led by First Star Ventures, with participation from several institutional investors. The company aims to utilize its CellForge™ platform for enhanced precision in cell development. This innovative approach could accelerate advancements in drug discovery and regenerative medicine.

Company Information

Company

iOrganBio

Location

Chapel Hill, North Carolina, United States

About

iOrganBio is pioneering the development of CellForge™, the first AI-powered cell manufacturing platform. Founded by experts in biomedical engineering and stem cell biology, the company aims to transform the production of human cells and organoids. Its technology utilizes AI-driven predictions and high-throughput experimental control to enhance reproducibility and scalability in cell manufacturing. iOrganBio's platform is designed to support advancements in drug discovery, regenerative medicine, and cell therapies.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns